CPT code 68550 designates surgical excision of the lacrimal gland via an approach that involves cutting into surrounding bony orbital structures, performed to remove a potentially malignant tumor with the specimen sent for pathologic analysis. This code captures a complex oculoplastic procedure with implications for surgical planning, perioperative care, and pathology services, and is relevant for facility and physician billing in operative ophthalmology.

Key national payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for lacrimal gland tumor excision, typical sites of service (hospital operating room or ambulatory surgery center), and common billing considerations tied to operative classification. The publication provides benchmarks and payment context where available, outlines billing nuances associated with an orbitotomy approach, and summarizes coding considerations that affect claim adjudication and facility-versus-professional responsibilities. It also highlights areas where policy updates or payment variability commonly occur for complex orbital procedures.

Intended for clinicians, coding professionals, and policy analysts, the report provides actionable clarity on the scope and clinical intent of 68550, plus the billing and administrative topics stakeholders commonly review when managing claims for lacrimal gland tumor excision.